Sight Sciences (SGHT) EBT Growth (1y) (2021 - 2026)
Sight Sciences (SGHT) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 74.66% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 103.34% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -27.02% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sight Sciences | 253.53 Mn | 168.57 Mn | 16.98 Mn | 8.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.11% |
| Dec 31, 2025 | 64.82% |
| Sep 30, 2025 | 24.33% |
| Jun 30, 2025 | 3.35% |
| Mar 31, 2025 | 13.15% |
| Dec 31, 2024 | -10.55% |
| Sep 30, 2024 | 15.88% |
| Jun 30, 2024 | 16.49% |
| Mar 31, 2024 | 4.71% |
| Dec 31, 2023 | 36.79% |
| Sep 30, 2023 | 41.66% |
| Jun 30, 2023 | 38.13% |
| Mar 31, 2023 | 26.67% |
| Dec 31, 2022 | -6.69% |
| Sep 30, 2022 | -29.48% |
| Jun 30, 2022 | -35.47% |
| Mar 31, 2022 | -90.79% |
| Dec 31, 2021 | -74.25% |
| Sep 30, 2021 | -112.05% |
| Jun 30, 2021 | -111.71% |